QR kód

Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens

Safeguarding patients from emerging infectious diseases demands strategies that prioritise patient well-being and protection. Immunobridging is an established trial methodology which has been increasingly employed to ensure patient protection and provide clinicians with swift access to vaccines. It...

Celý popis

Uloženo v:
Hlavní autoři: Pedro Cruz, Jie Min Lam, Jehad Abdalla, Samira Bell, Jola Bytyci, Tal Brosh-Nissimov, John Gill, Ghady Haidar, Michael Hoerger, Yasmin Maor, Antonio Pagliuca, Francois Raffi, Ffion Samuels, Dorry Segev, Yuxin Ying, Lennard Y. W. Lee
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI AG 2024-12-01
Edice:Vaccines
Témata:
immunobridging
clinical trials
immunocompromise
vaccines
monoclonal antibodies
On-line přístup:https://www.mdpi.com/2076-393X/13/1/19
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky